The Belgian biotech company Galapagos is closing its cell therapy division. This means that the company’s Leiden site, once a ...

Dermatology is thriving with innovation, from smart oral drugs to gene-therapy based fixes for rare skin diseases and skin ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.

There are currently no available treatment options for more than 90% of the approximately 7,000 rare diseases identified to ...

Overall and event-free survival of 100 and 95%, respectively, seen with autologous CD34+ hematopoietic stem-cell lentiviral gene therapy.

By combining proteasome inhibitors with Lys05, a drug that impairs autophagy, the team was able to shut down AML’s detour. In ...

Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are ...

After a chaotic year that has seen the attrition of over half the FDA’s senior leadership, many of these individuals have ...

The trial was small — just 12 children were treated in one or both ears — but it offers important lessons for researchers ...